DK2946007T3 - Reprogrammering af humant endothelium til hematopoietiske multilinje-stamceller af definerede faktorer - Google Patents
Reprogrammering af humant endothelium til hematopoietiske multilinje-stamceller af definerede faktorer Download PDFInfo
- Publication number
- DK2946007T3 DK2946007T3 DK14740745.6T DK14740745T DK2946007T3 DK 2946007 T3 DK2946007 T3 DK 2946007T3 DK 14740745 T DK14740745 T DK 14740745T DK 2946007 T3 DK2946007 T3 DK 2946007T3
- Authority
- DK
- Denmark
- Prior art keywords
- hematopoytic
- multiline
- stamps
- defined factors
- reprogramming human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/145—Thrombopoietin [TPO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2303—Interleukin-3 (IL-3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2306—Interleukin-6 (IL-6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/28—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from vascular endothelial cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361752688P | 2013-01-15 | 2013-01-15 | |
PCT/US2014/011575 WO2014113415A1 (en) | 2013-01-15 | 2014-01-15 | Reprogramming of human endothelium into hematopoietic multi-lineage progenitors by defined factors |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2946007T3 true DK2946007T3 (da) | 2019-07-15 |
Family
ID=51210017
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK14740745.6T DK2946007T3 (da) | 2013-01-15 | 2014-01-15 | Reprogrammering af humant endothelium til hematopoietiske multilinje-stamceller af definerede faktorer |
Country Status (10)
Country | Link |
---|---|
US (1) | US10113149B2 (da) |
EP (1) | EP2946007B1 (da) |
JP (1) | JP6581906B2 (da) |
CN (1) | CN105051184B (da) |
AU (1) | AU2014207627B2 (da) |
CA (1) | CA2898180C (da) |
DK (1) | DK2946007T3 (da) |
ES (1) | ES2733909T3 (da) |
RU (1) | RU2691062C2 (da) |
WO (1) | WO2014113415A1 (da) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201210857D0 (en) | 2012-06-19 | 2012-08-01 | Cambridge Entpr Ltd | Transcription factor mediated programming towards megakaryocytes |
ES2896354T3 (es) | 2012-12-21 | 2022-02-24 | Astellas Inst For Regenerative Medicine | Métodos para la producción de plaquetas a partir de células madre pluripotentes |
CN105051061B (zh) | 2013-01-30 | 2020-02-21 | 康奈尔大学 | 用于扩增干细胞的组合物和方法 |
AU2015279552B2 (en) | 2014-06-27 | 2021-01-21 | Angiocrine Bioscience, Inc. | Neural cells expressing adenovirus E4ORF1, and methods of making and using the same |
WO2016187820A1 (zh) * | 2015-05-26 | 2016-12-01 | 中国科学院广州生物医药与健康研究院 | 一种人原代细胞培养基及其应用 |
US20210040452A1 (en) * | 2015-06-09 | 2021-02-11 | The Regents Of The University Of California | Hematopoietic cells and methods of using and generating the same |
ES2939635T3 (es) * | 2015-07-20 | 2023-04-25 | Angiocrine Bioscience Inc | Métodos y composiciones para el trasplante de células madre |
JP6861438B2 (ja) | 2015-07-20 | 2021-04-21 | アンジオクライン・バイオサイエンス・インコーポレイテッドAngiocrine Bioscience, Inc. | Ets転写因子を発現する改変内皮細胞 |
AU2016362508B2 (en) * | 2015-12-03 | 2021-07-01 | Children's Medical Center Corporation | Methods for generating functional hematopoietic stem cells |
EP3394250A4 (en) * | 2015-12-23 | 2019-11-27 | Monash University | ZELLENNEUPROGRAMMIERUNG |
JP7080184B2 (ja) * | 2016-04-15 | 2022-06-03 | アンジオクライン・バイオサイエンス・インコーポレイテッド | 遺伝子送達の増強方法 |
WO2017192708A1 (en) * | 2016-05-03 | 2017-11-09 | The Children's Medical Center Corporation | Hematopoietic stem and progenitor cells derived from hemogenic endothelial cells |
IL265352B2 (en) | 2016-09-13 | 2024-05-01 | Angiocrine Bioscience Inc | Blood brain barrier containing engineered endothelial cells |
US11932876B2 (en) | 2017-02-03 | 2024-03-19 | Cornell University | Stable three-dimensional blood vessels and methods for forming the same |
EP3621630A4 (en) * | 2017-06-14 | 2021-03-10 | The Children's Medical Center | HEMATOPOIETIC STEM AND PRECURSOR CELLS FROM HEMOGENIC ENDOTHELIAL CELLS BY EPISOMAL PLASMID GENERAL TRANSFER |
WO2019183508A1 (en) * | 2018-03-23 | 2019-09-26 | The Children's Medical Center Corporation | Endothelial cell factors and methods thereof |
CN108676777A (zh) * | 2018-04-03 | 2018-10-19 | 华南生物医药研究院 | 胎肝窦内皮细胞株在造血干细胞扩增和分化中的应用 |
CN110577967A (zh) * | 2018-05-22 | 2019-12-17 | 中国人民解放军军事科学院军事医学研究院 | 诱导性多能干细胞及其制备方法 |
CN114051530A (zh) * | 2019-06-27 | 2022-02-15 | 昭和电工材料株式会社 | 细胞支架材料、细胞培养支撑体、以及细胞的培养方法 |
US20220354901A1 (en) * | 2019-07-03 | 2022-11-10 | Cornell University | Methods of functional vascularization of pancreatic islets and beta-cell organoids |
WO2023064284A1 (en) * | 2021-10-12 | 2023-04-20 | Wisconsin Alumni Research Foundation | Derivation of hepatocytes and hematopoietic progenitors from human embryonic stem cells |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2556018A1 (en) * | 2004-02-11 | 2005-09-09 | Aldagen, Inc. | Stem cell populations and methods of use |
WO2005100549A1 (ja) * | 2004-04-14 | 2005-10-27 | Kanazawa University Technology Licensing Organization Ltd. | 臓器特異的幹細胞の増殖方法及び増殖装置 |
RU2359030C1 (ru) * | 2008-03-19 | 2009-06-20 | Общество С Ограниченной Ответственностью "Лаборатория Клеточных Технологий" | Способ получения эндотелиальных клеток из эмбриональных стволовых клеток человека (варианты) |
JP5725394B2 (ja) * | 2009-03-25 | 2015-05-27 | 公立大学法人大阪府立大学 | 造血幹細胞の培養方法 |
EP2630232A4 (en) * | 2010-10-22 | 2014-04-02 | Biotime Inc | METHOD FOR MODIFYING TRANSCRIPTIONAL REGULATORY NETWORKS IN STEM CELLS |
WO2012109208A2 (en) | 2011-02-08 | 2012-08-16 | Cellular Dynamics International, Inc. | Hematopoietic precursor cell production by programming |
-
2014
- 2014-01-15 RU RU2015134394A patent/RU2691062C2/ru active
- 2014-01-15 US US14/760,773 patent/US10113149B2/en active Active
- 2014-01-15 EP EP14740745.6A patent/EP2946007B1/en active Active
- 2014-01-15 DK DK14740745.6T patent/DK2946007T3/da active
- 2014-01-15 CN CN201480015604.1A patent/CN105051184B/zh active Active
- 2014-01-15 CA CA2898180A patent/CA2898180C/en active Active
- 2014-01-15 AU AU2014207627A patent/AU2014207627B2/en active Active
- 2014-01-15 ES ES14740745T patent/ES2733909T3/es active Active
- 2014-01-15 WO PCT/US2014/011575 patent/WO2014113415A1/en active Application Filing
- 2014-01-15 JP JP2015552909A patent/JP6581906B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
EP2946007A4 (en) | 2016-06-08 |
CN105051184A (zh) | 2015-11-11 |
CN105051184B (zh) | 2018-08-10 |
RU2691062C2 (ru) | 2019-06-10 |
US10113149B2 (en) | 2018-10-30 |
CA2898180C (en) | 2023-09-26 |
AU2014207627B2 (en) | 2019-09-12 |
RU2015134394A (ru) | 2017-02-21 |
CA2898180A1 (en) | 2014-07-24 |
US20150361398A1 (en) | 2015-12-17 |
WO2014113415A1 (en) | 2014-07-24 |
JP2016505266A (ja) | 2016-02-25 |
EP2946007B1 (en) | 2019-04-10 |
AU2014207627A1 (en) | 2015-08-06 |
ES2733909T3 (es) | 2019-12-03 |
JP6581906B2 (ja) | 2019-09-25 |
EP2946007A1 (en) | 2015-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2946007T3 (da) | Reprogrammering af humant endothelium til hematopoietiske multilinje-stamceller af definerede faktorer | |
DK3087183T3 (da) | Modulation af angiopoietin-3-lignende ekspression | |
DK3121164T3 (da) | Sulfamoylpyrrolamidderivater og anvendelse deraf som medikamenter til behandling af hepatitis b | |
DK2968208T3 (da) | Behandling af kataplexi | |
DK2906696T4 (da) | Fremgangsmåder til modulering af c9orf72-ekspression | |
DK2992098T3 (da) | Sammensætninger og fremgangsmåder til modulering af hbv- og ttr-ekspression | |
DK2961388T3 (da) | Kombinationer af lægemidler | |
DK3035802T3 (da) | Kontrolleret vækst af mikroorganismer | |
BR302013004392S1 (pt) | Configuração aplicada emmetal sanitário | |
BR302013004540S1 (pt) | Configuração aplicada em jóias | |
BR302013004506S1 (pt) | Configuração aplicada em jóias | |
BR302013004355S1 (pt) | Configuração aplicada em jóias | |
DK2981255T3 (da) | Terapeutiske anvendelser af empagliflozin | |
DK3068776T3 (da) | Inhibitorer af replikation af influenzavira | |
DK3461895T3 (da) | Modulation af ube3a-ats-ekspression | |
DK3010352T3 (da) | Fremgangsmåde til fremstilling af fodertilsætning | |
DK2968284T3 (da) | Alkyl-amin-harminderivater til fremme af knoglevækst | |
DK3003285T3 (en) | Fast farmaceutisk dosisform til frigivelse af mindst to aktive farmaceutiske ingredienser i mundhulen | |
DK3470018T3 (da) | Kryokonservering af levedygtige menneskehudssubstitutter | |
DK2961378T3 (da) | Fremgangsmåder til behandlingen af mitochondrisk sygdom | |
DK3024519T3 (da) | Destruktion af hypodermiske kanyler | |
DK2965026T3 (da) | Generering af slushice | |
DK3152309T3 (da) | Anvendelse af mikropeptider til at fremme plantevækst | |
DK2948143T3 (da) | Anvendelse af phenoxypropylaminforbindelser til behandling af depression | |
FR3009951B1 (fr) | Prothese intra-laryngee |